Article Details

Sunesis Pharmaceuticals (NASDAQ:SNSS) Upgraded by Wells Fargo & Co to Outperform

Retrieved on: 2018-01-04 08:11:15

Tags for this article:

Click the tags to see associated articles and topics

Sunesis Pharmaceuticals (NASDAQ:SNSS) Upgraded by Wells Fargo & Co to Outperform. View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC lifted its stake in shares of Sunesis Pharmaceuticals by 1.1% during the first quarter. <b>Renaissance Technologies</b> LLC now owns 111,811 shares of the biopharmaceutical company's stock worth $458,000 after buying an additional 1,230 shares during the period. Finally ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up